lifestyle.faithfamilyamerica.com

Author: Precipio, Inc.

Precipio Announces Q1-2026 Shareholder Update Call

May 6, 2026
Precipio Announces Q4 and year-end 2025 Shareholder Update Call

March 12, 2026
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay

March 10, 2026
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year

February 25, 2026